Novartis launches third-to-market Remicade copy in Germany

Novartis launched a copy of Johnson& Johnson's (J&J) inflammation-fighting Remicade in Germany on Thursday as the Swiss drugmaker aims to catch rival biosimilars that are already available in Europe's largest healthcare market.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news